Announce Date | 05/15/2025 |
EPS Normalized Actual | $-2.18 (Miss by $-2.22) |
EPS GAAP Actual | $-2.18 (Miss by $-2.22) |
Revenue Actual | $5.3944B |
Revenue Surprise | Beat by $5394.4M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.70668 |
EPS GAAP Estimate | $2.70668 |
Revenue Estimate | $1.219220024B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 2.44886 | 0.2 | 2.33086 | 2.63978 | 1 |
Dec 2026 | 7.13622 | 0.07 | 6.80907 | 7.51142 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 32.07 | 32.10248521 | 5.3944B | 13.27% | 4360.52M |
FQ4 2024 (Dec 2024) | -12.69 | -15.28864 | 5.54545B | 9.29% | 4420.06M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 5.1296B | 4.2% | -4476.55M |
FQ2 2024 (Jun 2024) | -10.96 | -12.30259 | 4.17274B | -2.32% | -4366.06M |
FQ1 2024 (Mar 2024) | -9.66 | -11.23645 | 4.6784B | 4.27% | -2793.05M |
FQ4 2023 (Dec 2023) | 1.16 | 1.31 | 5.0304B | 100% | 3970.4M |
FQ2 2013 (Jun 2013) | -0.81 | -0.81 | 1.19765B | 100% | 1197.65M |
FQ1 2014 (Mar 2014) | -0.1 | -0.1 | 1.38698B | 100% | 1386.98M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.70668
Consensus Revenue Estimates
1.219220024B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 2.35094 | -- | 2.35094 | 2.35094 | 3 |
FQ3 2026 (Sep 2026) | 2.0325 | -- | 2.0325 | 2.0325 | 3 |
FQ2 2026 (Jun 2026) | -0.56846 | -- | -0.56846 | -0.56846 | 3 |
FQ1 2026 (Mar 2026) | -0.20804 | 15515.3 | -0.20804 | -0.20804 | 3 |
FQ4 2025 (Dec 2025) | 3.21751 | 494.4 | 2.93985 | 3.39054 | 1 |
FQ3 2025 (Sep 2025) | 2.70668 | -- | 2.4731 | 2.85224 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 5.93B | -- | 5.93B | 5.93B | 4 |
FQ3 2026 (Sep 2026) | 5.56B | -- | 5.56B | 5.56B | 4 |
FQ2 2026 (Jun 2026) | 4.74B | -- | 4.74B | 4.74B | 4 |
FQ1 2026 (Mar 2026) | 4.78B | -12.76 | 4.78B | 4.78B | 4 |
FQ4 2025 (Dec 2025) | 1.23B | -349.77 | 1.15B | 1.28B | 1 |
FQ3 2025 (Sep 2025) | 1.22B | -320.73 | 1.14B | 1.27B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.03248521 | 32.07 | 32.10248521 | 100.1% |
FQ4 2024 (Dec 2024) | 2.59864 | -12.69 | -15.28864 | 120.48% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 1.34259 | -10.96 | -12.30259 | 112.25% |
FQ1 2024 (Mar 2024) | 1.57645 | -9.66 | -11.23645 | 116.32% |
FQ4 2023 (Dec 2023) | -0.15 | 1.16 | 1.31 | 112.93% |
FQ2 2013 (Jun 2013) | -0.81 | -0.81 | 100% | |
FQ1 2014 (Mar 2014) | -0.1 | -0.1 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.03B | $5.39B | $4360.52M | 80.83% |
FQ4 2024 (Dec 2024) | $1.13B | $5.55B | $4420.06M | 79.71% |
FQ3 2024 (Sep 2024) | $9.61B | $5.13B | $-4476.55M | -87.27% |
FQ2 2024 (Jun 2024) | $8.54B | $4.17B | $-4366.06M | -104.63% |
FQ1 2024 (Mar 2024) | $7.47B | $4.68B | $-2793.05M | -59.7% |
FQ4 2023 (Dec 2023) | $1.06B | $5.03B | $3970.4M | 78.93% |
FQ2 2013 (Jun 2013) | $0B | $1.2B | $1197.65M | 100% |
FQ1 2014 (Mar 2014) | $0B | $1.39B | $1386.98M | 100% |